Alan Crane Insider Profile
4 Followers
Alan Crane, Director, Ten Percent Owner at Daré Bioscience, holds 0.00 shares in Pandion Therapeutics (Ticker: PAND), holds 30.00K shares in T2 Biosystems (Ticker: TTOO), holds 4.77M shares in Daré Bioscience (Ticker: DARE).
Alan Crane's Trading History
You May Also Like
Alan Crane insider profile FAQ
What is the percentage of profitable transactions made by Alan Crane?
The percentage of profitable transactions made by Alan Crane is 0%.
What is the average return per transaction made by Alan Crane?
The average return per transaction made by Alan Crane is -10.10%.
What stocks does Alan Crane hold?
Alan Crane holds: DARE, PAND, MNTA, TTOO stocks.
What was Alan Crane’s latest transaction?
Alan Crane’s latest transaction was an Uninformative Sell of $217.31M.
What was Alan Crane's most profitable transaction?
Alan Crane’s most profitable transaction was an Informative Buy of DARE stock on April 15, 2014. The return on the trade was -1.80%.
What is Alan Crane's role in Daré Bioscience?
Alan Crane's role in Daré Bioscience is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
